跳至主要内容
临床试验/EUCTR2011-005863-25-BE
EUCTR2011-005863-25-BE进行中(未招募)1 期

Gastrointestinal behavior of tenofovir DF in healthy volunteers - Gastrointestinal behavior of tenofovir DF

Katholieke Universiteit Leuven - Pharmacotechnology and Biopharmacy0 个研究点目标入组 5 人开始时间: 2012年1月19日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - healthy volunteers
  • - age between 18 and 35
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - pregnancy
  • - use of medication
  • - regular exposure to X-radiation last year

研究者

发起方
Katholieke Universiteit Leuven - Pharmacotechnology and Biopharmacy

相似试验

进行中(未招募)
1 期
Measuring concentrations of the drug atazanavir along the gastrointestinal tract in human subjects after oral administration of the drug product
EUCTR2017-004579-29-BEKU Leuven Drug Delivery & Disposition15
进行中(未招募)
1 期
The effect of two related HIV-medicines (TDF and TAF) on small intestine gut wall - could that explain why TDF seems to decrease and TAF to increase body weightHIV-positive people who have good and stable treatment response for HIV-medication which includes either tenofovir disoproxil (TDF) or tenoforvir alafenamide (TAF)
EUCTR2022-000849-32-FIHelsinki University Hospital24
已完成
3 期
Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks: a prospective, open-label, randomized controlled trialTenofovir disoproxil fumarate (TDF)&#45induced nephrotoxicity in HIV infected patientsTDF induced nephrotoxicity&#44switching&#44virological response&#44abacavir&#44lopinavir/ritonavir
TCTR20190708002none84
招募中
不适用
In-vivo Bioequivalence Test of Tenofovir Alafenamide tablets with brand drug (Vemlidy® 25 mg, Gilead, Canada)Bio equivalence test.
IRCT20200105046010N52Sobhan Trade Pharmaceutical Company24
已完成
不适用
A study for correlation of molecular target gene polymorphism and pharmacokinetics of tenofovir alafenamideHepatitis B
ITMCTR1900002285onghua Hospital Shanghai University of Traditional Chinese Medicine